Report cover image

Over the Counter (OTC) Analgesics Market

Publisher Coherent Market Insights
Published Jul 14, 2025
Length 172 Pages
SKU # CMI20302974

Description

Analgesics are medicines that are used to relieve pain. They are also known as painkillers or pain relievers. These are a class of medicines designed specifically to relieve pain. They include several classes of drugs (such as non-steroidal anti-inflammatory drugs, acetaminophen, antiepileptics, antidepressants, opioids, and local anesthetics).

Market Dynamics

Rise in prevalence chronic diseases, increase in adoption of OTC analgesics or rise in consumption of OTC analgesics, rise in geriatric population, and rise in demand for narcotics analgesic drugs are major factors expected to drive growth of the global over the counter (OTC) analgesics market.

For instance, in December 2021, Heron Therapeutics, Inc. announced that the U.S. Food & Drug Administration (FDA) approved its supplemental New Drug Application (sNDA) for ZYNRELEF (bupivacaine and meloxicam) extended-release solution to significantly expand the indication.

Moreover, in July 2021, Heron Therapeutics announced the commercial launch and availability of ZYNRELEF in the U.S. for the management of postoperative pain for up to 72 hours.

Key features of the study
  • This report provides in-depth analysis of the over the counter (OTC) analgesics market, and provides market size (USD Bn) and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global over the counter (OTC) analgesics market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Sanofi SA, Reckitt Benckiser Group PLC, Pfizer Inc., Mylan NV, GlaxoSmithKline PLC, Johnson & Johnson, Bayer, Takeda Pharmaceutical, and Sun Pharmaceutical Industries Ltd., among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global over the counter (OTC) analgesics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global over the counter (OTC) analgesics market.
Market Segmentation
  • Global Over the Counter (OTC) Analgesics Market, By Type of Drug
  • Acetaminophen
  • Nonsteroidal Anti- inflammatory Drug (NSAIDs)
  • Salicylates
  • Other Analgesics
  • Global Over the Counter (OTC) Analgesics Market, By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others Distribution Channels
  • Global Over the Counter (OTC) Analgesics Market, By Geography
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
  • Company Profiles
  • Sanofi SA
  • Reckitt Benckiser Group PLC
  • Pfizer Inc.
  • Mylan NV
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • Bayer AG
  • Takeda Pharmaceutical
  • Sun Pharmaceutical Industries Ltd.

Table of Contents

172 Pages
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Type of Drug
Market Snapshot, By Distribution Channel
Market Snapshot, By Geography
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
High prevalence chronic diseases and rise in geriatric population
Drug tolerance, dependence, and addiction and abuse
Increase in adoption or rise in consumption of OTC analgesics
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER’s Analysis
Merger and Acquisition Scenario
4. Global Over the Counter (OTC) Analgesics Market, By Type of Drug, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 – 2032
Segment Trends
Acetaminophen
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Bn)
Nonsteroidal Anti-Inflammatory Drug (NSAIDs)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Bn)
Salicylates
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Bn)
Other Analgesics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Bn)
5. Global Over the Counter (OTC) Analgesics Market, By Distribution Channel, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 – 2032
Segment Trends
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Bn)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Bn)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Bn)
Others Distribution Channels
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Bn)
6. Global Over the Counter (OTC) Analgesics Market, By Geography, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 – 2032
Segment Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(USD Bn)
U.S.
Canada
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(USD Bn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(USD Bn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(USD Bn)
Brazil
Argentina
Mexico
Rest of Latin America
Middle East and Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(USD Bn)
GCC Countries
Israel
Rest of Middle East
South Africa
North Africa
Central Africa
7. Competitive Landscape
Sanofi SA
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Reckitt Benckiser Group PLC
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Pfizer Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Mylan NV
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
GlaxoSmithKline PLC
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Johnson & Johnson
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Bayer AG
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Takeda Pharmaceutical
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Sun Pharmaceutical Industries Ltd.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Analyst Views
8. Section
Research Methodology
About us

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us